Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 3/19/14  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Peter Mueller

Wrong Dr. Peter Mueller?

Executive Vice President, Global ...

Phone: (617) ***-****  HQ Phone
Email: p***@***.com
Local Address: Natick, Massachusetts, United States
Vertex Pharmaceuticals Incorporated
130 Waverly Street
Cambridge, Massachusetts 02139
United States

Company Description: Vertex Pharmaceuticals Incorporated (Vertex) is engaged in the business of discovering, developing and commercializing small molecule drugs for the treatment of...   more
Background

Employment History

Board Memberships and Affiliations

Education

  • Ph.D
  • Ph.D. , Chemistry
    Albert Einstein University of Ulm , Germany
  • undergraduate degree
    Albert Einstein University of Ulm , Germany
  • PhD
170 Total References
Web References
...
www.sec.gov, 19 Mar 2014 [cached]
0001256126 MUELLER PETER C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 EVP, Global R&D, CSO
Executive Team | vrtx.com
www.vrtx.com, 16 Nov 2013 [cached]
Peter Mueller
...
Peter Mueller, Ph.D. Executive Vice President, Global Research and Development, and Chief Scientific Officer
Dr. Mueller joined Vertex in 2003 and is the company's Executive Vice President, Global Research and Development, and Chief Scientific Officer. He is responsible for Vertex's research and development activities, including clinical and non-clinical development, clinical operations and medical and regulatory affairs for all of Vertex's medicines in development. Read more
Prior to joining Vertex, Dr. Mueller was the Senior Vice President, Research and Development, of Boehringer Ingelheim Pharmaceuticals, Inc., with responsibility for the development of all drug candidates in the company's worldwide portfolio in North America. During his time with Boehringer Ingelheim, Dr. Mueller oversaw the discovery, development and approval of numerous development candidates and held several positions in basic research, medicinal chemistry and management. Dr. Mueller received both an undergraduate degree and a Ph.D. in chemistry at the Albert Einstein University of Ulm, Germany, where he also holds a Professorship in Theoretic Organic Chemistry. He completed fellowships in quantum pharmacology at Oxford University and in biophysics at Rochester University.
USA India Chamber of commerce - Delivering Affordable Innovation through Global Partnerships
www.usaindiachamber.org, 27 July 2013 [cached]
Peter Mueller
...
Dr. Peter Mueller Executive Vice President Global R&D & CSO Vertex Pharmaceuticals
USA India Chamber of commerce - BioTech, Pharmaceuticals, Healthcare Council
www.usaindiachamber.org, 27 July 2013 [cached]
Peter Mueller, Ph.D. Chief Scientific Officer and Executive Vice President
Peter Mueller, ...
www.inhibikase.com, 20 Oct 2013 [cached]
Peter Mueller, PhD.
Dr. Mueller joined Vertex in July 2003. As Executive Vice President Global Research and Development & Chief Scientific Officer, he provides strategic oversight for Vertex's worldwide drug discovery research programs, Pharmaceutical Development, Quality Assurance and Control, Pharmaceutical Operations as well as Clinical and Non-Clinical Development, Regulatory, Patient Safety and Medical Affairs. Key areas of Vertex' R&D are Hepatitis C, Cystic Fibrosis, IMID, Cancer, and Neurological Diseases which led in 2011 to the successful approval and launch of INCIVEK (HepC), a NDA/MAA submission for KALYDECO (CF) with the first approval in the US in January 2012 and several proof of clinical concept candidates in various disease areas. Prior to coming to Vertex, Dr. Mueller served as Senior Vice President, Research and Development, for Boehringer Ingelheim Pharmaceuticals, Inc. where he was responsible for the development of all drug candidates of the company's worldwide portfolio in North and South America, Canada and Japan, beginning in 1997. He also led research programs in the areas of immunology, inflammation, cardiovascular disease and gene therapy on a global basis. During his time with Boehringer Ingelheim, Dr. Mueller oversaw the discovery of numerous development candidates, held several positions in basic research, medicinal chemistry and management in different centers of BI worldwide.
Dr. Mueller received both an undergraduate degree and a Ph.D. in Chemistry at the Albert Einstein University of Ulm, Germany, where he also holds a Professorship in Theoretical Organic Chemistry. He completed fellowships in Quantum Pharmacology at Oxford University and in Biophysics at Rochester University.
Other People with the name "Mueller":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304